By Steve|2024-10-11T15:58:53+13:00June 25th, 2024|Categories: All, Trials & Studies, Z-Legacy|Tags: MTAP Loss|
Claire and Steve Holmes have poured everything into building a foundation that champions, initiates, and funds science, research, and best practices—dedicated to ensuring it reaches and benefits patients today and every day. Their commitment has never wavered, but they cannot do this alone. Now, your support is critical—an essential catalyst to propel their vision even further. Please join us in this transformative mission.
“Alone we can do so little; together we can do so much.”
— Helen Keller
A symbol of extraordinary resilience and achievement over seemingly impossible obstacles.
$30 helps provide current information to patients and caregivers
$50 provides a navigator journal to a patient or caregiver
$100 supports our online meetings connecting and sharing patients journey
$250 provides one on one peer-to-peer telephone and video support
$500 assists with mentor programs and patient endorsed medical registries
$1000 supports resarch and advancements to benefit today’s patient survival
Cholangiocarcinoma Foundation Australia is registered as a charity with the Australian Charities and Not-for-Profits Commission (ACNC). Cholangiocarcinoma Foundation Australia has Deductible Gift Recipient (DGR) status with the Australian Tax Office. Donations over $2 or more are tax-deductible. ABN: 93 665 038 102
The Empowered Patient is uniquely positioned and equipped to understand, engage, and succeed by utilizing a process that integrates scientific advancements, evidence-based medicine, and human resilience attributes into a comprehensive response strategy.
Fully embracing the concept of an empowered patient will advance science, reshape the healthcare response, and close the unattended gap between early detection and late-stage diagnosis.